“The compound SR-17018 is the primary biased agonist with the mu opioid receptor that does not result in tolerance with chronic use,” suggests Stahl, a senior staff members scientist while in the Bohn lab. “It is a desirable aspect for probable use inside the context of Persistent, severe suffering.” https://9royalstreet.com/product/sr-17018-vendor/